Paper Details

  1. Home
  2. Paper Details

Zaleplon improves sleep quality in maintenance hemodialysis patients.

Author: CesaroAntonio, CianciarusoBruno, CrispoAnna, FedericoStefano, MirenghiFrancesco, PisaniAntonio, RagostaAnnalisa, SabbatiniMassimo

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Zaleplon, a nonbenzodiazepine hypnotic drug, was found to significantly improve sleep quality in maintenance hemodialysis patients with insomnia.
Paper Details　
Original Abstract of the Article :
BACKGROUND/AIM: A recent survey has shown that insomnia is still a very common problem in maintenance hemodialysis (MHD) patients. The aim of the present study was to test the effects of zaleplon (ZAL), a new nonbenzodiazepine hypnotic drug, on the sleep quality of MHD patients with insomnia. METHO...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/12972720

データ提供：米国国立医学図書館（NLM）

Zaleplon: A New Hope for Sleepless Nights in Hemodialysis Patients

Sleep, a vital restorative process, can be elusive for patients undergoing maintenance hemodialysis (MHD). This study explores the effectiveness of zaleplon, a nonbenzodiazepine hypnotic drug, in improving sleep quality in MHD patients with insomnia. The study found that zaleplon significantly improved sleep quality, reducing sleep latency and increasing sleep efficacy, without any significant adverse effects. This research provides promising insights into the potential of zaleplon as a safe and effective treatment for insomnia in MHD patients.

Restoring Sleep in Hemodialysis Patients

This study offers a glimmer of hope for MHD patients suffering from insomnia. The findings suggest that zaleplon can effectively improve sleep quality in these patients, potentially leading to improved overall well-being and quality of life.

The Importance of Sleep for Health and Wellbeing

The study underscores the vital role of sleep in overall health and well-being. By improving sleep quality in MHD patients, zaleplon may contribute to their physical and mental health, enhancing their ability to cope with the challenges of chronic kidney disease.

Dr. Camel's Conclusion

Imagine a weary camel, traversing a vast desert, yearning for a restful slumber. Zaleplon, like a soothing oasis, provides a respite from the sleepless nights of hemodialysis, allowing these weary travelers to find solace and rejuvenation in the desert of their illness.

Date :
  1. Date Completed 2003-10-20
  2. Date Revised 2017-11-01
Further Info :

Pubmed ID

12972720

DOI: Digital Object Identifier

72493

Related Literature

Article Analysis
・Side Effects of zaleplon
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.